1. Home
  2. HALO vs W Comparison

HALO vs W Comparison

Compare HALO & W Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$100.98

Market Cap

14.8B

Sector

Health Care

ML Signal

N/A

Logo Wayfair Inc.

W

Wayfair Inc.

N/A

Current Price

$110.76

Market Cap

15.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
W
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
15.5B
IPO Year
2001
2014

Fundamental Metrics

Financial Performance
Metric
HALO
W
Price
$100.98
$110.76
Analyst Decision
Buy
Buy
Analyst Count
9
33
Target Price
$119.89
★ $137.69
AVG Volume (30 Days)
★ 2.3M
2.2M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.15
EPS
★ 5.12
N/A
Revenue
★ $151,862,000.00
N/A
Revenue This Year
$35.97
$8.42
Revenue Next Year
$14.85
$8.19
P/E Ratio
$19.84
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$61.23
$55.60
52 Week High
$134.00
$127.99

Technical Indicators

Market Signals
Indicator
HALO
W
Relative Strength Index (RSI) 27.51 49.24
Support Level $64.08 $110.00
Resistance Level $111.15 $118.31
Average True Range (ATR) 4.64 6.20
MACD -3.78 -0.74
Stochastic Oscillator 6.04 5.89

Price Performance

Historical Comparison
HALO
W

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About W Wayfair Inc.

Wayfair engages in e-commerce in the United States (88% of 2025 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with 13 stores (excluding outlets) between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. The firm offers more than 40 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, as well as advertising and logistics services. Wayfair was founded in 2002 and began trading publicly in 2014.

Share on Social Networks: